title: Evaluating the place of low-molecular-weight heparin in the management of acute coronary syndromes. A panel discussion with audience participation.
authors: The Cardiovascular Institute, Mount Sinai Hospital, New York, New York 10029, USA.
authors: J H
authors: JH
authors: Chesebro
authors: F W
authors: FW
authors: Verheugt
authors: F
authors: F
authors: Kontny
authors: E T
authors: ET
authors: Fry
authors: L
authors: L
authors: Wallentin
authors: A J
authors: AJ
authors: Camm
authors: H
authors: H
authors: Bechtold
mesh_terms: D000789:Angina, Unstable / Q000188:drug therapy*; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications; D017985:Dalteparin / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D015912:Thrombolytic Therapy
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D017985:Dalteparin